Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL
Authors
Keywords
-
Journal
Hematology-American Society of Hematology Education Program
Volume 2013, Issue 1, Pages 335-341
Publisher
American Society of Hematology
Online
2013-12-06
DOI
10.1182/asheducation-2013.1.335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NK Cells Lyse T Regulatory Cells That Expand in Response to an Intracellular Pathogen
- (2014) S. Roy et al. JOURNAL OF IMMUNOLOGY
- CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
- (2013) M. L. Green et al. BLOOD
- Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset
- (2013) E. M. Mace et al. BLOOD
- Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy
- (2013) Isabela Pedroza-Pacheco et al. Cellular & Molecular Immunology
- Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2
- (2013) Jonathan Sitrin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-2–dependent adaptive control of NK cell homeostasis
- (2013) Georg Gasteiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
- (2013) Georg Gasteiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regulatory T cells in stem cell transplantation: Main characters or walk-on actors?
- (2012) Claudio Fozza et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Postallograft lenalidomide induces strong NK cell–mediated antimyeloma activity and risk for T cell–mediated GvHD: Results from a phase I/II dose-finding study
- (2012) Christine Wolschke et al. EXPERIMENTAL HEMATOLOGY
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1
- (2012) Jeffrey M. Venstrom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-Versus-Host Disease
- (2011) K. L. Hippen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
- (2011) A. H. Elmaagacli et al. BLOOD
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
- (2011) B. Foley et al. BLOOD
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- Regulatory T cells in stem cell transplantation: strategies and first clinical experiences
- (2011) Matthias Edinger et al. CURRENT OPINION IN IMMUNOLOGY
- Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells
- (2011) Christoph Bergmann et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
- (2011) S. Lopez-Verges et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T Cells: Customizing for the Clinic
- (2011) X. Wang et al. Science Translational Medicine
- Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity
- (2011) K. L. Hippen et al. Science Translational Medicine
- Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4+CD25highCD127low/− regulatory T cells
- (2010) Sya N. Ukena et al. ANNALS OF HEMATOLOGY
- Decreased Infections in Recipients of Unrelated Donor Hematopoietic Cell Transplantation from Donors with an Activating KIR Genotype
- (2010) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Early Lymphocyte Recovery and Outcomes after Umbilical Cord Blood Transplantation (UCBT) for Hematologic Malignancies
- (2010) Michael J. Burke et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
- (2010) J. A. Olson et al. BLOOD
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation
- (2010) Ken-ichi Matsuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Decrease of CD4+CD25+ regulatory T cells and TGF-β at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation
- (2010) Qing Li et al. LEUKEMIA RESEARCH
- CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation
- (2010) S. Maury et al. Science Translational Medicine
- Impact of Cytomegalovirus (CMV) Reactivation after Umbilical Cord Blood Transplantation
- (2009) Jill C. Beck et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
- (2009) Maria Berg et al. CYTOTHERAPY
- Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning
- (2009) James L. Riley et al. IMMUNITY
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
- (2009) Ethan M. Shevach IMMUNITY
- Foxp3+ regulatory T cells: differentiation, specification, subphenotypes
- (2009) Markus Feuerer et al. NATURE IMMUNOLOGY
- The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
- (2008) Christine Galustian et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NK cells and Treg cells: A fascinating dance cheek to cheek
- (2008) Jacques Zimmer et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started